Entegrion, which has developed a bleeding control dressing called Stasilon using technology developed at the University of North Carolina at Chapel Hill, has licensed Stasilon to a Chicago firm.
Financial terms were not disclosed.
Beeken BioMedical said it intends to “continue development and commercialization” of Stasilon.
For details, read here.
Get the latest news alerts: Follow WRAL Tech Wire at Twitter.
